GeneTex中国官方网站
  • China

血管生成

Angiogenesis

Angiogenesis entails the generation of new blood vessels from pre-existing vasculature. It is an intricate process tightly regulated by input from pro- and anti-angiogenic factors. In the normal adult, the balance between these inducers and inhibitors maintains a quiescent state that nevertheless is capable of rapid changes in response to micro-environmental disruptions secondary to wounds, hypoxia, or inflammation. Perturbations of this balance in various chronic pathological conditions and tumors can lead to inappropriate angiogenesis or neovascularization. The mechanistic features underlying angiogenesis are complex, but the clinical importance of being able to modulate this process means that this will remain a compelling and dynamic field of research.

GeneTex is proud to offer an extensive line of research antibodies to support the study of angiogenesis. Please see the highlighted products below or click the button to see more product information.

See All Related Products

 

Highlighted Products

Citation-Support Comparable Abs Orthogonal Validation
VEGF antibody (GTX132777)

VEGF antibody (GTX132777)

VEGF Receptor 2 antibody (GTX129943)

VEGF Receptor 2 antibody (GTX129943)

CD31 antibody (GTX130274)

CD31 antibody (GTX130274)

 
Angiopoietin 2 antibody (GTX100928)

Angiopoietin 2 antibody (GTX100928)

TIE1 antibody [12D9] (GTX52470)

TIE1 antibody [12D9] (GTX52470)

 
TIE2 antibody [21G7] (GTX52471)

TIE2 antibody [21G7] (GTX52471)

 
 
 
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Promotion
奔跑吧!科研-高质量抗体,让您的研究进入快车道!

奔跑吧!科研-高质量抗体,让您的研究进入快车道!

奔跑吧!科研-高质量抗体,让您的研究进入快车道!
Articles
五大验证策略

五大验证策略

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter

GeneTex推出RAS (G12D突变体) 重组抗体 [HL10]

GeneTex的RAS(G12D突变体)重组抗体适用于IHC染色和WB。
Newsletter

「胶」你怎么做!Western blot省时小密技

Literature
下载 GeneTex 最新版本的 血管生成 单页

单页 - 血管生成

下载 GeneTex 最新版本的 血管生成 单页
Promotion
GeneTex 抗体百元试用计划 - 体验质量 试用启航

GeneTex 抗体百元试用计划 - 体验质量 试用启航

Newsletter

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Newsletter

Dogs Provide Great Help to Human Cancer Research

Dogs Provide Great Help to Human Cancer Research
Newsletter
exosome PD-L1

Improving cancer immunotherapy efficacy may depend on targeting exosomes

Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Pathways

Epithelial–mesenchymal transition (EMT) Pathway

EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.
Literature
RNA 结合蛋白

单页 - RNA 结合蛋白

下载 GeneTex 最新版本的RNA结合蛋白单页
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
血管生成研究

单页 - 血管生成研究

下载 GeneTex 最新版本的血管生成研究单页
Literature
癌症免疫检查点

单页 - 癌症免疫检查点

下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature

海报 - 癌症信号

下载GeneTex最新版本的癌症信号海报
Literature

折页 - 癌症相关领域

下載GeneTex最新版本的癌症相关领域折页
Literature
下载 GeneTex 最新版本的 血管生成 单页

单页 - 血管生成

下载 GeneTex 最新版本的 血管生成 单页
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature
RNA 结合蛋白

单页 - RNA 结合蛋白

下载 GeneTex 最新版本的RNA结合蛋白单页
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
血管生成研究

单页 - 血管生成研究

下载 GeneTex 最新版本的血管生成研究单页
Literature
癌症免疫检查点

单页 - 癌症免疫检查点

下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature

海报 - 癌症信号

下载GeneTex最新版本的癌症信号海报
Literature

折页 - 癌症相关领域

下載GeneTex最新版本的癌症相关领域折页